Today: 9 June 2026
Browse Category

NASDAQ:CMND 13 November 2025 - 18 November 2025

Clearmind Medicine (CMND) Delivers Positive AUD Trial Data Amid New Depression Patent – Nov. 18, 2025

Clearmind Medicine (CMND) Delivers Positive AUD Trial Data Amid New Depression Patent – Nov. 18, 2025

Clearmind Medicine reported positive safety results from the first cohort of its FDA-approved Phase I/IIa trial of CMND-100 for alcohol use disorder. No serious adverse events were observed among six participants treated at Johns Hopkins and Yale. CMND shares surged to $0.39 intraday on heavy volume before settling near $0.27 by mid-afternoon November 18. The company also announced a new Israeli patent filing and an expected equity offering.
18 November 2025
··
Clearmind Medicine (CMND) Stock Soars as FDA‑Regulated Alcohol Use Disorder Trial Expands to Hadassah – November 13, 2025

Clearmind Medicine (CMND) Stock Soars as FDA‑Regulated Alcohol Use Disorder Trial Expands to Hadassah – November 13, 2025

Clearmind Medicine shares surged Thursday after the company received final approval to expand its FDA-regulated Phase 1/2a trial for Alcohol Use Disorder to Hadassah Medical Center in Jerusalem. The firm also filed for a registered direct offering of shares and pre-funded warrants, raising new capital but prompting dilution concerns among investors. The trial now includes sites at Yale, Johns Hopkins, Tel Aviv Sourasky, and Hadassah.
13 November 2025
··

Stock Market Today

  • Quantinuum's British Founder Becomes Billionaire After $15 Billion IPO
    June 9, 2026, 2:12 PM EDT. Quantinuum, a quantum computing firm, went public with a $15 billion initial public offering (IPO). The company's British founder has become a billionaire following the IPO, marking a significant milestone in the quantum technology sector. This IPO highlights growing investor interest in advanced computing technologies and underscores the financial potential of the quantum computing industry.

Latest articles

AHMA Shares Jump Over 100% With Little News Out

AHMA Shares Jump Over 100% With Little News Out

9 June 2026
Ambitions Enterprise Management Co. L.L.C shares soared 185% to $3.08 on Nasdaq with over 60 million shares traded, despite no new company news since April 30; the surge outpaced travel peers and left the price below its $4 IPO, with the company warning in its annual report of potential volatility, competition, seasonal risks, and a $5 million capital need.
Rigetti Drops 14% With Quantum Names Hit in Tech Selloff

Rigetti Drops 14% With Quantum Names Hit in Tech Selloff

9 June 2026
Rigetti shares plunged 14.4% to $18.64, erasing gains from bullish Bernstein commentary, as investors dumped high-growth tech stocks sector-wide despite analyst optimism on quantum computing’s future; the drop followed a director’s proposed stock sale and comes as Rigetti awaits finalization of a potential $100 million federal award.
Archer Aviation Drops After Cathie Wood Selloff; What Traders Are Tracking

Archer Aviation Drops After Cathie Wood Selloff; What Traders Are Tracking

9 June 2026
Archer Aviation plunged 9.1% to $5.21 after ARK Invest dumped over 2.2 million shares worth $12.7 million, intensifying pressure as investors fled speculative growth stocks; with FAA certification still pending and heavy cash burn, Archer’s stock remains vulnerable to further selloffs if milestones slip.
Aurora Shares Fall as Uber Pulls Back, Tech Stocks Struggle

Aurora Shares Fall as Uber Pulls Back, Tech Stocks Struggle

9 June 2026
Aurora shares dropped 3.5% to $6.04 as tech and autonomous-driving stocks slid, with Uber’s recent block sale of 67.5 million shares at $7.10 still weighing on sentiment; Aurora reported a Q1 net loss of $223 million on $1 million revenue, expects continued losses, and may need to raise more capital to support its commercial ramp.
Go toTop